Here is an encouraging article about reversing hearing loss:
Novartis AG (NOVN) is developing a gene therapy that may reverse hearing loss by stimulating the regrowth of microscopic hair cells in the inner ear, allowing people to hear. The hairs are destroyed by prolonged exposure to loud noise, and don't take root again naturally. Novartis treated the first patient in October after successful tests on rats.
Novartis plans to test its treatment on 45 patients in the US, with results expected by 2017, according to a description of the trial on clinicaltrials.gov.
The therapy uses a disabled cold causing virus that enters so-called supporting cells in the inner ear, where it delivers its payload--a gene called atonal-1 that tells the cells to grow in to hair cells.
Novartis AG (NOVN) is developing a gene therapy that may reverse hearing loss by stimulating the regrowth of microscopic hair cells in the inner ear, allowing people to hear. The hairs are destroyed by prolonged exposure to loud noise, and don't take root again naturally. Novartis treated the first patient in October after successful tests on rats.
Novartis plans to test its treatment on 45 patients in the US, with results expected by 2017, according to a description of the trial on clinicaltrials.gov.
The therapy uses a disabled cold causing virus that enters so-called supporting cells in the inner ear, where it delivers its payload--a gene called atonal-1 that tells the cells to grow in to hair cells.